Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%

Advances in Human Augmentation: We Can Rebuild Him

By Olga Kharif - 2012-03-07T02:05:27Z

Courtesy Abiomed Inc.

Company Symbol % Change
11 of 16

Improved Hemodynamics

Symphony
Abiomed Inc.

Abiomed unveiled Symphony in November, calling it a minimally invasive, implantable device designed to improve hemodynamics, or the circulation of blood through the cardiovascular system. It's aimed at alleviating angina and heart failure symptoms. The first in-person procedure using Symphony has been scheduled for early this year, outside the U.S.

Advertisement